Company · CIK 0001157601 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 SForm 4 → | Sep 11, 4:57 pm EDT | William John SiboldPresident and CEO, Director | 11,583 | $538.65 | $6,239,198 | 197,746 | −5.53% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.